Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Anaphylactic shock | x | x | ||
Anaemia megaloblastic | x | x | ||
Anorexia | x | x | ||
Toxic epidermal necrolysis | x | x | ||
Erythema multiforme | x | x | ||
Haematuria | x | x | ||
Hypersensitivity | x | x | ||
Leukopenia | x | x | ||
Pancytopenia | x | x | ||
Pulmonary eosinophilia | x | x | ||
Stevens-Johnson syndrome | x | x | ||
Thrombocytopenia | x | x | ||
Vomiting | x | x | ||
Atrophic glossitis | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Malaria | x | |||
Toxoplasmosis | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |